Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VVoyager Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

Voyager Therapeutics, Inc.

$3.14Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $3.17M. Net result −$24.47M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $3.17M. Running result $3.17M. Revenue: $3.17M.
  • Cost of revenue: $0. Running result $3.17M.
  • Gross profit: $3.17M. Running result $3.17M.
  • Research and development: −$22.04M. Running result −$18.88M.
  • General and administrative: −$7.52M. Running result −$26.39M.
  • Operating income: −$26.39M. Running result −$26.39M.
  • Other income: $1.94M. Running result −$24.45M.
  • Pre-tax loss: −$24.45M. Running result −$24.45M.
  • Income tax expense: −$20K. Running result −$24.47M.
  • Net loss: −$24.47M. Running result −$24.47M.